Chondrex provides two IgE monoclonal antibodies specific to ovalbumin
(OVA), clone E-C1 and clone E-G6, in addition to one IgG1 monoclonal
antibody against OVA, clone L71. In general, the cross-linkage of IgE
molecules bound to the receptor on mast cells by a polyvalent allergen
is required to trigger degranulation of mast cells. Alternatively, IgG
antibody to the allergens can trigger the activation of mast cells by
cross-linking two antigens bound by IgE antibodies on mast cell
surfaces. However, E-C1 alone is capable of inducing degranulation of
mast cells in vitro (Figure 1), and severe hypersensitivity reaction in
vivo (Figure 2). Therefore, it is assumed that E-C1 might recognize
repetitive epitopes of OVA. Futhermore, it has been reported that
aggregated OVA carrying multiple epitopes, increases the formation of
cross-linkage of IgE on mast cell surfaces. On the other hand, E-G5 is
not capable of inducing these hypersensitivity reactions by itself in
vitro and in vivo (Figures 1 and 2), and can be used as a control.
Figure 1 - Degranulation of mast cells by monoclonal IgE antibody
1A - Comparison of three monoclonal antibodies
1B - Dose response of EC-1 and E-G5
Figure 2 - Foot pad hypersensitivity reaction induced by EC-1 in Balb/c mice